Par Pharmaceutical Engaged in Illegal Drug-Switching Scheme, U.S. Says—9/6/11
In a whistleblower lawsuit, the U.S. alleges that a leading company in drug making and distribution defrauded government healthcare systems by engaging in a nationwide illegal drug-switching scheme. The whistleblower lawsuit became public this week in a Chicago federal court. Twenty states and the District of Columbia have joined the lawsuit filed under the False Claims Act.
Read more at: http://www.bloomberg.com/news/print/2011-09-06/mylan-units-implicated-in-u-s-lawuit-against-par-alleging-drug-switching.html